HHLR ADVISORS, LTD. - Q2 2022 holdings

$4.67 Billion is the total value of HHLR ADVISORS, LTD.'s 64 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was - .

 Value Shares↓ Weighting
BABA NewALIBABA GROUP HLDG LTDsponsored ads$214,969,0001,891,000
+100.0%
4.61%
PDD NewPINDUODUO INCsponsored ads$86,516,0001,399,928
+100.0%
1.85%
JKS NewJINKOSOLAR HLDG CO LTDsponsored adr$78,894,0001,140,416
+100.0%
1.69%
BZ NewKANZHUN LIMITEDsponsored ads$21,713,000826,199
+100.0%
0.46%
MSFT NewMICROSOFT CORP$10,273,00040,000
+100.0%
0.22%
NFLX NewNETFLIX INC$7,869,00045,000
+100.0%
0.17%
TSLA NewTESLA INC$7,138,00010,600
+100.0%
0.15%
AMZN NewAMAZON COM INC$6,373,00060,000
+100.0%
0.14%
LU NewLUFAX HOLDING LTD$6,000,0001,000,000
+100.0%
0.13%
DEO NewDIAGEO PLCspon adr new$5,224,00030,000
+100.0%
0.11%
OIH NewVANECK ETF TRUSToil services etf$4,652,00020,000
+100.0%
0.10%
SHOP NewSHOPIFY INCcl a$4,686,000150,000
+100.0%
0.10%
NewCHINA JO-JO DRUGSTORES INC$887,000403,334
+100.0%
0.02%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings